DJ DXS International plc Director/Pdmr Shareholding
TIDMDXSP DXS INTERNATIONAL PLC Director Dealing The Board of DXS International plc (the "Company"), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that it has been notified that the Chief Executive, David Immelman, has purchased 20,002 Ordinary Shares at a price of 9.9p per share on 30 November 2018. Following the transaction specified above Mr Immelman holds 3,677,541 Ordinary Shares representing 10.45% of the issued share capital of the Company. The Directors of DXS International plc accept responsibility for this announcement Enquiries: David Immelman (Chief 01252 719800 Executive) email@example.com DXS International plc Wrecclesham House Wrecclesham Road Farnham Surrey GU10 4PS www.dxs-systems.co.uk David Papworth 0207 101 7676 City & Merchant firstname.lastname@example.org Level 17, Dashwood House 69 Old Broad Street, London EC2M 1QS Note to Editors: DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.
(END) Dow Jones Newswires
December 04, 2018 08:00 ET (13:00 GMT)